Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Tyrosine-protein kinase Lck | ||
Ligand | BDBM50105742 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_221305 | ||
IC50 | 18±n/a nM | ||
Citation | Adams, JL; Boehm, JC; Gallagher, TF; Kassis, S; Webb, EF; Hall, R; Sorenson, M; Garigipati, R; Griswold, DE; Lee, JC Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett11:2867-70 (2001) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
Tyrosine-protein kinase Lck | |||
Name: | Tyrosine-protein kinase Lck | ||
Synonyms: | 2.7.10.2 | LCK | LCK_HUMAN | LSK | Leukocyte C-terminal Src kinase | Lymphocyte cell-specific protein-tyrosine kinase | Lymphocyte-specific protein tyrosine kinase | P56-LCK | Protein YT16 | Proto-oncogene Lck | Proto-oncogene tyrosine-protein kinase LCK | Src/Lck kinase | T cell-specific protein-tyrosine kinase | ||
Type: | n/a | ||
Mol. Mass.: | 57987.83 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P06239 | ||
Residue: | 509 | ||
Sequence: |
| ||
BDBM50105742 | |||
n/a | |||
Name | BDBM50105742 | ||
Synonyms: | 4-[4-(4-Fluoro-phenyl)-5-(2-methoxy-pyrimidin-4-yl)-imidazol-1-yl]-cyclohexanol | CHEMBL97162 | trans -1-(4-hydroxycyclohexyl)-4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)imidazole | ||
Type | Small organic molecule | ||
Emp. Form. | C20H21FN4O2 | ||
Mol. Mass. | 368.4047 | ||
SMILES | COc1nccc(n1)-c1c(ncn1[C@H]1CC[C@H](O)CC1)-c1ccc(F)cc1 |wU:16.18,wD:13.14,(3.13,-3.72,;3.16,-2.18,;4.5,-1.42,;4.53,.13,;5.87,.86,;7.2,.06,;7.17,-1.48,;5.82,-2.22,;8.5,-2.27,;8.7,-3.8,;10.21,-4.09,;10.93,-2.74,;9.88,-1.62,;10.17,-.1,;11.64,.4,;11.93,1.91,;10.77,2.91,;11.06,4.43,;9.31,2.4,;9.02,.89,;7.63,-4.91,;8.06,-6.39,;6.98,-7.48,;5.49,-7.1,;4.43,-8.22,;5.06,-5.63,;6.14,-4.53,)| | ||
Structure |